Abstract

Background: Pre-eclampsia is the leading reason for referrals to a specialized healthcare facility, as it represents a significant contributor to maternal and perinatal morbidity and mortality.

Objective:The objective of this study is to examine the maternal and fetal outcomes associated with severe pre-eclampsia in a Tertiary Care Center.

Design: Prospective observational study.

Methodology: This prospective observational study took place at Dr. Prabhakar Kore Hospital and MRC, located in Belagavi and affiliated with KAHER's Jawaharlal Nehru Medical College, Belagavi. The study spanned from January 1, 2021, to December 31, 2021. Pregnant women diagnosed with severe Pre-eclampsia, which met the specified inclusion and exclusion criteria, and were admitted to the labor room at the tertiary care center, were enrolled in the study.

Results: Participants in the study ranged in age from 19 to 41 years, with a mean gestational age at diagnosis of 35.32 weeks ±3.7 weeks. Among the participants, 73.4% underwent lower segment cesarean section (LSCS), while 22.4% had vaginal deliveries, including 3 cases with instrumental delivery (ventouse). The study observed increased incidences of Hemolysis, Elevated Liver enzymes, and Low Platelet count (HELLP) syndrome (32.4%), placental abruption (30%), postpartum hemorrhage (22%), partial HELLP syndrome (16.2%), pulmonary edema (11%), eclampsia and disseminated intravascular coagulation (DIC) (8.1%). The incidence of prematurity was 55%, and intrauterine fetal demise (IUFD) occurred in 7% of the cases.

Conclusion: Maternal and perinatal problems are more common in eclampsia patients. Better prenatal care, early detection, and timely treatment of severe pre-eclampsia can lower the incidence of eclampsia.

• 1.   Upadya M, Rao ST. Hypertensive disorders in pregnancy. Indian J Anaesth. 2018 Sep;62(9):675.
• 2.   Nobis PN, Hajong A. Eclampsia in India through the decades. J Obstet Gynaecol India. 2016 Oct;66:172–6.
• 3.   American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122.
• 4.   Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785–99.
• 5.   Mammaro A, Carrara S, Cavaliere A, Ermito S, Dinatale A, Pappalardo EM, et al. Hypertensive disorders of pregnancy. J Prenat Med. 2009 Jan;3(1):1.
• 6.   Patnaik US, Devi GR, Anusha K, Suseela AV. Maternal and perinatal outcome in severe pre-eclampsia. IAIM. 2019;6(10):43–9.
• 7.   Saxena N, Bava AK, Nandanwar Y. Maternal and perinatal outcome in severe Pre-eclampsia and eclampsia. Int J Reprod Contracept Obstet Gynecol. 2016 Jul 1;5(7):2171–7.
• 8.   Sahu S, Abraham RE, Vedavalli R, Daniel MA. Study of lipid profile, lipid peroxidation and vitamin E in pregnancy induced hypertension. Indian J Physiol Pharmacol. 2009 Oct 1;53(4):365–9.
• 9.   Katz O, Paz-Tal O, Lazer T, Aricha-Tamir B, Mazor M, Wiznitzer A, et al. Severe pre-eclampsia is associated with abnormal trace elements concentrations in maternal and fetal blood. J Matern Fetal Neonatal Med. 2012 Jul 1;25(7):1127–30.
• 10.   Swamy MK, Patil K, Nageshu S. Maternal and perinatal outcome during expectant management of severe pre-eclampsia between 24 and 34 weeks of gestation. J Obstet Gynaecol India. 2012 Aug;62:413–8.
• 11.   Pillai SS. Fetomaternal outcome in severe Preeclampsia and eclampsia: a retrospective study in a tertiary care centre. Int J Reprod Contracept Obstet Gynecol. 2017 Sep 1;6(9):3937–41.
• 12.   Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol. 2005 Feb 1;105(2):402–10.
• 13.   Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, Casey BM, et al. Williams obstetrics. New York: McGraw-Hill Medical; 2014.
• 14.   Murphy DJ, Stirrat GM. Mortality and morbidity associated with early-onset Pre-eclampsia. Hypertens Pregnancy. 2000 Jan 1;19(2):221–31.
• 15.   Singhal S, Deepika, Anshu, Nanda S. Maternal and perinatal outcome in severe Pre-eclampsia and eclampsia. South Asian Federation of Obstetrics and Gynecology. 2009;1(3):25–8.
• 16.   George P, Thankachi VJ. Hellp syndrome-a study from a tertiary centre in India. J Contemp Med Res. 2017;4(7):1604–6.
• 17.   Ngwenya S, Jones B, Mwembe D. Determinants of adverse maternal and perinatal outcomes in severe Pre-eclampsia and eclampsia in a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe. BMC Res Notes. 2019 Dec;12:1–5.
• 18.   Turgut NH, Temiz TK, Bagcivan I, Turgut B, Gulturk S, Karadas B. The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model. Eur J Pharmacol. 2008 Jul 28;589(1-3):180–7.
• 19.   Tuffnell DJ, Jankowicz D, Lindow SW, Lyons G, Mason GC, Russell IF, et al. Outcomes of severe pre eclampsia/eclampsia in Yorkshire 1999/2003. BJOG. 2005 Jul;112(7):875–80.

Data Sharing Statement

Funding